Stuart Poulton

EVP, Chief Development Officer

EVP, Chief Development Officer at Karyopharm Therapeutics Inc., filing insider transactions on 2026-07-28.

Total Purchases

—

0 transactions

Total Sales

$1K

1 transaction

Companies Traded

1 total filings

Active Since

2026-07-28

Last: 2026-07-28

Companies

Karyopharm Therapeutics Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-28	KPTI	Sale	189	$7.10	$1K	94.6K	SEC ↗